Immediate Impact
1 by Nobel laureates 3 from Science/Nature 63 standout
Citing Papers
Obesity in adults
2024 Standout
The benefits of GLP-1 drugs beyond obesity
2024 StandoutScience
Works of Guy Pelletier being referenced
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset
2023
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Guy Pelletier | 24 | 308 | 24 | 89 | 37 | 24 | 472 | |
| James R. Fowler | 15 | 324 | 21 | 8 | 26 | 456 | ||
| T. Matilsky | 2 | 445 | 22 | 133 | 31 | 533 | ||
| Francisco Peña-Benítez | 190 | 347 | 13 | 29 | 545 | |||
| Kenneth C. Jacobs | 3 | 423 | 3 | 282 | 14 | 456 | ||
| Philip Lu | 22 | 252 | 230 | 28 | 439 | |||
| George Greenstein | 2 | 326 | 38 | 106 | 41 | 447 | ||
| Alexander S. Blum | 1 | 87 | 1 | 277 | 3 | 42 | 445 | |
| H. G. Mitchell | 8 | 520 | 12 | 74 | 27 | 564 | ||
| M. Peracaula | 5 | 413 | 7 | 244 | 21 | 491 | ||
| M. I. Moretti | 510 | 6 | 46 | 27 | 530 |
All Works
Loading papers...